HIGHLIGHTS
- who: P from the Department of Pathology, Radboudumc, Nijmegen, the Netherlands Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands have published the research work: Mutation-tailored treatment selection in non-small cell lung cancer patients in daily clinical practice, in the Journal: (JOURNAL) of June/30,/2018
- what: The aim of this study was to provide a national overview of uptake of molecular diagnostics and targeted therapy in patients with NSCLC, the breadth of targets tested, and the inter-laboratory variation of these aspects. The authors present a comprehensive evaluation of molecular testing . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.